For decades, doctors and scientists have been locked in a "Chicken and Egg" mystery. When someone has a heart attack, their arteries are filled with two specific things: fatty buildup (lipids) and signs of a "swelling" immune response (inflammation).
Imagine a man named Sam. Sam is the kind of person we all want to be. He runs five miles every morning, he eats plenty of colorful vegetables, and he avoids junk food. When Sam went to his yearly check-up, his doctor had great news. The doctor looked at Sam’s blood test and said, "Your numbers are perfect! Your total cholesterol is low, and your LDL looks great. Your heart is in tip-top shape."
For decades, preventive cardiology has been anchored by a single, powerful concept: the "lipid hypothesis." We operated under the assumption that cholesterol accumulation—specifically LDL-C—was the primary driver of atherosclerotic cardiovascular disease. The clinical directive was straightforward: push LDL-C down, and heart attack risk will follow. While this approach, largely driven by statin therapy, has undeniably saved millions of lives, we now know it is an incomplete strategy.
